The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
New multivalent cationic lipids reveal bell curve for transfection efficiency versus membrane charge density: lipid–DNA complexes for gene delivery
Abstract
Background: Gene carriers based on lipids or polymers—rather than on engineered viruses—constitute the latest technique for delivering genes into cells for gene therapy. Cationic liposome–DNA (CL‐DNA) complexes have emerged as leading nonviral vectors in worldwide gene therapy clinical trials. To arrive at therapeutic dosages, however, their efficiency requires substantial further improvement. Methods: Newly synthesized multivalent lipids (MVLs) enable control of headgroup charge and size. Complexes comprised of MVLs and DNA have been characterized by X‐ray diffraction and ethidium bromide displacement assays. Their transfection efficiency (TE) in L‐cells was measured with a luciferase assay. Results: Plots of TE versus the membrane charge density (σ M, average charge/unit area of membrane) for the MVLs and monovalent 2,3‐dioleyloxypropyltrimethylammonium chloride (DOTAP) merge onto a universal, bell‐shaped curve. This bell curve leads to the identification of three distinct regimes, related to interactions between complexes and cells: at low σ M, TE increases with increasing σ M; at intermediate σ M, TE exhibits saturated behavior; and unexpectedly, at high σ M, TE decreases with increasing σ M. Conclusions: Complexes with low σ M remain trapped in the endosome. In the high σ M regime, accessible for the first time with the new MVLs, complexes escape by overcoming a kinetic barrier to fusion with the endosomal membrane (activated fusion), yet they exhibit a reduced level of efficiency, presumably due to the inability of the DNA to dissociate from the highly charged membranes in the cytosol. The intermediate, optimal regime reflects a compromise between the opposing demands on σ M for endosomal escape and dissociation in the cytosol. Copyright © 2005 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · cited 1×
“Recent setbacks in clinical trials with viral vectors, in particular a fatality induced by a severe inflammatory response [4] and insertional mutagenesis caused by retroviral vectors [5], have further promoted a diligent effort in developing efficient nonviral methods.”
Background
Cited by
Current Progress in Gene Delivery Technology Based on Chemical Methods and Nano-Carriers
Jin, L., Zeng, X., Liu, M., Deng, Y., & He, N. (2014) · Theranostics · doi:10.7150/thno.6914 · Cited by 388
Lipoplex morphologies and their influences on transfection efficiency in gene delivery
Ma, B., Zhang, S., Jiang, H., Zhao, B., & Lv, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.022 · Cited by 326
The Headgroup Evolution of Cationic Lipids for Gene Delivery
Zhi, D., Zhang, S., Cui, S., Zhao, Y., Wang, Y., & Zhao, D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300381s · Cited by 271
Advances in gene delivery through molecular design of cationic lipids
Bhattacharya, S., & Bajaj, A. (2009) · Chemical Communications · doi:10.1039/b900666b · Cited by 264
Nanoparticle-based technologies for retinal gene therapy
Adijanto, J., & Naash, M. I. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.028 · Cited by 107
Metadata
- Authors
- Ahmad, A., Evans, H. M., Ewert, K., George, C. X., Samuel, C. E., & Safinya, C. R.
- Venue
- The Journal of Gene Medicine
- Publisher
- Wiley
- Published
- 2005-01-31
- Volume
- 7
- Issue
- 6
- Pages
- 739-748
- ISSN
- 1099-498X (ISSN-L)
- 1521-2254
- OpenAlex
- W2105277037
- Cited by
- 184
- References
- 1
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.